- 報道写真・映像トップ 報道写真・映像トップ
- 写真・グラフィックス・映像 | 写真・グラフィックス・映像 |
「サブユニットワクチン」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 共同通信社
0
- 国内提供元
0
- 海外提供元
0
- 日付
- 24時間以内
0 - 48時間以内
0 - 72時間以内
0 - 7日以内
0 - 30日以内
0 - 1年以内
0 - 期間を指定
11 - 日付指定なし
11
- 種類
- 写真
11 - グラフィックス
0 - 映像
0
- 向き
- 縦
0 - 横
11 - 正方形
0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー
11 - モノクロ
0
- 同義語辞書
- オン
- オフ
- 古い順
- 1
- 古い順
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A health worker is showing a vile of CORBEVAX COVID-19 vaccine at a vaccination center in Kolkata , India , on 21 March 2022. Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032607771
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A health worker is showing a vile of CORBEVAX COVID-19 vaccine at a vaccination center in Kolkata , India , on 21 March 2022. Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032607780
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A little girl receives a dose of CORBEVAX vaccine at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608224
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A little girl receives a dose of CORBEVAX vaccine at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608227
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A little girl receives a dose of CORBEVAX vaccine at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608266
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A health worker is seen preparing a dose of CORBEVAX vaccine at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608263
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A little girl receives a dose of CORBEVAX vaccine at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608368
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A CORBEVAX vaccine as seen at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608372
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A CORBEVAX vaccine as seen at a vaccination center in Kolkata , India , on 21 March 2022 .Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608125
本画像はログイン後にご覧いただけます
2022年03月21日CORBEVAX vaccination drive in India .March 21, 2022, Kolkata, West Bengal, India: A health worker is showing a vile of CORBEVAX COVID-19 vaccine at a vaccination center in Kolkata , India , on 21 March 2022. Indian government has announced a vaccination drive to vaccinate all children between the age of 12 to 14 years with CORBEVAX, which is India‘s first indigenously developed RBD-protein subunit vaccine , developed by hydrebad based Biological E Ltd (Credit Image: © Debarchan Chatterjee/ZUMA Press Wire)、クレジット:©Debarchan Chatterjee/ZUMA Press Wire/共同通信イメージズ
商品コード: 2022032608367
本画像はログイン後にご覧いただけます
2023年10月17日China‘s First Quadrivalent Subunit Influenza VaccineGUIYANG, CHINA - OCTOBER 17, 2023 - A medical worker shows China‘s first quadrivalent subunit influenza vaccine at a community health service center in Guiyang, Guizhou province, Oct. 17, 2023. (Photo by Costfoto/NurPhoto)、クレジット:Costfoto/NurPhoto/共同通信イメージズ ※NO USE CHINA
商品コード: 2023101800224
- 1
- 報道写真・映像トップ 報道写真・映像トップ
- 写真・グラフィックス・映像 | 写真・グラフィックス・映像 |